Arteris (NASDAQ:AIP) COO Laurent Moll Sells 32,775 Shares

Arteris, Inc. (NASDAQ:AIPGet Free Report) COO Laurent Moll sold 32,775 shares of Arteris stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $15.42, for a total value of $505,390.50. Following the completion of the transaction, the chief operating officer owned 311,110 shares in the company, valued at $4,797,316.20. The trade was a 9.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Arteris Stock Down 2.8%

Shares of AIP traded down $0.41 during trading hours on Friday, reaching $14.48. The company’s stock had a trading volume of 953,875 shares, compared to its average volume of 587,988. Arteris, Inc. has a 1-year low of $5.46 and a 1-year high of $15.92. The company has a 50 day moving average of $11.49 and a two-hundred day moving average of $9.58. The firm has a market cap of $632.49 million, a price-to-earnings ratio of -17.45 and a beta of 1.49.

Arteris (NASDAQ:AIPGet Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). Arteris had a negative net margin of 52.25% and a negative return on equity of 8,546.17%. The business had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. As a group, analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Institutional Investors Weigh In On Arteris

Institutional investors have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in Arteris in the 2nd quarter valued at $32,000. CWM LLC lifted its stake in Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock valued at $71,000 after purchasing an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Arteris during the 1st quarter valued at $95,000. Savant Capital LLC acquired a new stake in shares of Arteris during the second quarter valued at about $97,000. Finally, Kapitalo Investimentos Ltda bought a new position in shares of Arteris during the second quarter valued at $104,000. Institutional investors own 64.36% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on AIP. TD Cowen increased their price target on shares of Arteris from $15.00 to $16.50 and gave the stock a “buy” rating in a research report on Wednesday. Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Cowen reissued a “buy” rating on shares of Arteris in a research note on Wednesday. Rosenblatt Securities raised their target price on Arteris from $14.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, Jefferies Financial Group raised shares of Arteris to a “hold” rating in a report on Tuesday, October 28th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $17.50.

Read Our Latest Stock Analysis on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.